Evvy raises $40M as it seeks to further women’s health research with vaginal microbiome data
- ID
- 24652
- Status
- summarized
- Published
- 15 Sep 2026, 10:13 PM
- Fetched
- 15 Sep 2026, 10:29 PM
- Provider
- TechCrunch
- Category
- technology
- Original URL
- https://techcrunch.com/2026/09/15/evvy-raises-40m-as-it-seeks-to-further-womens-health-research-with-vaginal-microbiome-data/
- Source URL
- https://techcrunch.com/feed/
Summary
- Score
- 3.5
- Created
- 15 Sep 2026, 10:31 PM
- Tags
- Audience
- saas_foundersai_ml_learners
What happened
Women's health startup Evvy raised a $40M Series B led by Catalio Capital Management to expand its at-home vaginal microbiome testing and build a dataset linking microbiome biology, symptoms, interventions, and outcomes. The company serves over 100,000 U.S. patients and 3,000 practitioners, and has produced 15 peer-reviewed publications. CEO Priyanka Jain argues precision medicine is flawed because existing datasets inadequately measure female biology, and that leading AI models struggle with women's health questions.
Why it matters
For founders, this is a concrete example of building a defensible data moat in a vertical (women's health) where existing datasets are thin, which is a playbook relevant to anyone considering domain-specific AI products. For builders in Malaysia, the model of collecting proprietary clinical data to train better models is replicable in underserved health verticals locally, though the article itself is U.S.-focused and does not provide technical or implementation detail.
Discussion angle
How valuable is a proprietary vertical dataset as a moat when foundation models keep improving, and what underserved Malaysian health or domain data could support a similar play?